Hyperfine Announces 10 Abstracts At RSNA, Highlighting The Expanding Utility And Potential Of Portable MR Brain Imaging In Diverse Clinical And Research Settings
Hyperfine Announces 10 Abstracts At RSNA, Highlighting The Expanding Utility And Potential Of Portable MR Brain Imaging In Diverse Clinical And Research Settings
The breadth of data being presented at the premier radiology meeting of 2024 illustrates the increasing relevance of portable, ultra-low-field MR brain imaging.
在2024年首屈一指的放射學會議上公佈的數據範圍表明，便攜式超低場磁共振腦成像的重要性越來越大。
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop system—today announced that ten scientific abstracts highlighting ultra-low-field imaging will be presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago. For Hyperfine, this marks the largest number of presentations at RSNA to date, underscoring the growing interest in and expanding applications of the Swoop system across varied professional healthcare environments.
Hyperfine, Inc.（納斯達克股票代碼：HYPR）是一家開創性的健康科技公司，通過美國食品藥品管理局批准的首款便攜式磁共振（MR）腦成像系統——Swoop系統——今天宣佈，將在芝加哥舉行的北美放射學會（RSNA）2024年年會上發表十份重點介紹超低場成像的科學摘要。對於Hyperfine而言，這標誌着迄今爲止在RSNA上發表的演講數量最多，突顯了人們對Swoop系統的興趣與日俱增，並在各種專業醫療環境中擴展了其應用。
